EXEL and GILD Related Headlines
Go Back- GI Cancer Immunotherapy Breakthroughs Signal New Treatment Era
- The Institute for Follicular Lymphoma Innovation (IFLI) Appoints Innovative Leaders Mehrdad Mobasher, M.D., M.P.H., and Carol O'Hear, M.D., Ph.D., as Executive Partners
EXEL and GILD Related Press Releases
Go Back- GI Cancer Immunotherapy Breakthroughs Signal New Treatment Era
- The Institute for Follicular Lymphoma Innovation (IFLI) Appoints Innovative Leaders Mehrdad Mobasher, M.D., M.P.H., and Carol O'Hear, M.D., Ph.D., as Executive Partners

